Inventor
Brad D. MAXWELL
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry13%
Y02PClimate change mitigation technologies in the production or processing of goods7%
PatentTitleYear
12,421,249Inhibitors of APOL1 and methods of using same202512,084,452Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation202411,866,446Inhibitors of APOL1 and methods of using same202411,623,924Modulators of alpha-1 antitrypsin2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to VERTEX PHARMA (3)· patent assignee history
2023–2025Based in US· patent location history
2024Patents assigned to BRISTOL MYERS SQUIBB CO (1)· patent assignee history
2024Patents assigned to UNIV MONTREAL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 3 | 2023–2025 |
| BRISTOL MYERS SQUIBB CO | 1 | 2024 |
| UNIV MONTREAL | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2023–2025 |